Cardiol Therapeutics Inc. (TSX:CRDL)
1.220
-0.030 (-2.40%)
Nov 20, 2026, 4:00 PM EST
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Cardiol Therapeutics the 38,785th largest employer in the world and 696th in Canada.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-2.08M CAD
Market Cap
155.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | - | - |
| Dec 31, 2018 | 6 | - | - |
| Sep 30, 2018 | 8 | - | - |
| Jun 30, 2018 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cresco Labs | 2,900 |
| Ascend Wellness Holdings | 2,200 |
| Canopy Growth | 1,128 |
| Organigram Global | 1,120 |
| TerrAscend | 1,038 |
| Cannara Biotech | 452 |
| Medexus Pharmaceuticals | 90 |
| HLS Therapeutics | 85 |
Cardiol Therapeutics News
- 8 days ago - Cardiol Therapeutics Report: Q3 2026 - Filings
- 8 days ago - Cardiol Therapeutics MD&A: Q3 2026 - Filings
- 11 days ago - Cardiol Therapeutics Slides: Corporate presentation - Filings
- 17 days ago - Cardiol Therapeutics announces $75M ATM equity offering program - TheFly
- 17 days ago - Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC - PRNewsWire
- 1 month ago - Cardiol Therapeutics Slides: Corporate presentation - Filings
- 1 month ago - Cardiol Therapeutics achieves enrollment target for Phase III MAVERIC trial - TheFly
- 1 month ago - Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy - PRNewsWire